Stocks & ETFs

Latest News

Blogs & Articles

Stratagy Backtesting

Portfolio Analyser

Price Analyser

Compare Stocks

Stock & ETF Screener

Pricing

About The Company

CEO

Mr. Lianyue Song

Market Cap

15.62 Million USD

Sector

Consumer Cyclical

Website

http://www.hfgreathealth.com

Description

Hartford Great Health Corp.

Read More

Overview

Value

1

Growth

42

Health

6

Management

67

Analyst Opinion

69

Total

37

All Scores Out Of 100

Best Features

  • Earnings growth has improved recently
  • Has a low level of debt
  • Low preportion of income is paid as dividend

Risk Factors

  • Overvalued on cashflow basis
  • Income is not covering expenditure and investment
  • Earnings are negative
  • There is a history of diluting shareholders
  • 0
  • Does not hold enough liquid assets to cover short term liabilities
  • Poor overall financial health
  • No margin of safety at their current market price
  • 0

Market Peers

HFUS

Key Figures

PE Ratio (TTM)

N/A

Margin Of Safety (DCF)

-134.25%

Revenue Growth (5 Year Average)

10.09%

Ratings Consensus

Buy

Share Buybacks

-19.13%

Dividend Yeild (TTM)

N/A

Valuation

Value Score

1

  • Estimated intrinsic-value of NaN undefined USD is lower than current price ( 156.00 undefined USD)
  • Free-cashflow-yeild of -1.55% is worse than the market average (4.7%)
  • Margin-of-safety of -134.25% is worse than the market average (17.95%)

Desired Margin Of Safety

0%

Tip: Set your desired Margin Of Safety

Free Cash Flow Type

Annual Cashflow Growth

0%

Discount Rate

0%

Buy Target: N/A

Current Price: 0.2 USD

Negative Cashflows: Cashflow can become negative due to operating losses, investing activities or financing activites. Negative cashflow makes it dificult to use a discounted free cashflow model to assess intrinsic value.

How Does This Work?

Show Advanced Options

This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated target price for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel the impact this has on longterm investment returns and discover a margin of safety you are comfortable with. This can be a useful tool for investors looking to make informed decisions about whether to buy or sell shares of a particular company.

Price/Earnings

N/Ax

Free Cashflow Yeild

-1.55%

PE/Earnings Growth

N/A

Price/Book

-3.35x

Growth

Growth Score

42

  • Earnings growth has improved this year
  • 5 Year Average Cashflow growth of 15.02% is higher than the market average (12.35%)
  • Free Cashflow growth has improved this year
  • 5 Year Average Revenue growth of 10.09% is lower than the market average (10.97%)
  • Revenue growth has slowed this year
  • 5 Year Average Earnings growth of N/A is lower than the market average (14.48%)

Revenue Growth

10.09%

Earnings Growth

N/A

Cashflow Growth

15.02%

Health

Health Score

6

  • Has a low level of debt
  • Low financial Leverage
  • Normal operation does not require debt to be sustainable
  • Cashflow is negative
  • 0
  • Assets do not cover liabilities
  • Debt repayments significantly impact cashflow

Altman Z Score

N/A

Piostroski Score

3.00

Debt/Equity

N/Ax

Current Assets/Liabilities

0.02x

Free Cashflow/Total Debt

N/Ax

Debt/Capital

N/Ax

Management

Management Score

67

  • Has issued new shares to finance growth when share price is high
  • Return-on-capital-employed of -11.73% is lower than the market average (10%)
  • Has a history of diluting shareholders to finance activity
  • Return-on-equity of 11.16% is lower than the market average (15%)

Average Buybacks/Dilution

-19.13%

Recent Buybacks/Dilution

N/A

5 Year Price Volitility

79.17%

Return On Assets

-642.40%

Return On Capital Employed

-11.73%

Return On Equity

11.16%

Return On Free Cashflow

1948.36%

Return On Investments

N/A

Analysts

Analyst Opinion

69

  • Ratings consensus is Buy

SEC Filings

Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.

Other Information

Company Name

Hartford Great Health Corp.

Currency

USD

Beta

5.105716

Vol Avg

0

Ceo

Mr. Lianyue Song

Cik

0001482554

Cusip

Exchange

Other OTC

Full Time Employees

65

Industry

Lodging

Sector

Consumer Cyclical

Ipo Date

2012-04-05

Address

8832 Glendon Way

City

Rosemead

State

CA

Country

US

Zip

91770

Phone

626 321 1915

All financial data provided by FMP

Noticed an error with something on our site?

We Use Cookies